Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan
Conclusion: Preliminary findings indicate a promising potential of Silexan for the treatment of psychiatric manifestations in patients with post-COVID-19 syndrome.Key pointsAnxiety and mixed neuropsychiatric manifestations are commonly observed in patients with post-COVID-19 syndrome.Silexan has anxiolytic properties and can alleviate comorbid depressive, somatic, and sleep impairment symptoms.Silexan exhibits several biological mechanisms, such as neurotrophic and anti-inflammatory properties, which have the potential to positively impact post-COVID-19 disease.Silexan has a favourable safety profile and high acceptance am...
Source: International Journal of Psychiatry in Clinical Practice - April 6, 2023 Category: Psychiatry Authors: Siegfried Kasper Anne Eckert Hans-J ürgen Möller Hans-Peter Volz Erich Seifritz Source Type: research

Engendering misunderstanding: autism and borderline personality disorder
Conclusion: Clinicians must be encouraged to pursue thorough differential diagnoses, especially for women and transgender individuals who experience emotional lability with self-harm.KEY POINTSAutism is underdiagnosed in girls, women, and transgender individuals due both to diagnostic bias, and the quieter, less visible signs and symptoms of female autism.As females are so adept at camouflaging difference, distress generally only becomes manifest during mid childhood and adolescence, when mental illness gets misidentified as primary cause.Early mood difficulties often transform into more serious distress with emotional lab...
Source: International Journal of Psychiatry in Clinical Practice - March 17, 2023 Category: Psychiatry Authors: Jay Watts Source Type: research